Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dilapan-S®: A Multicenter US E-registry

NCT04451109 is registered in ClinicalTrials.gov with Medicem Technology s.r.o. as lead sponsor.

NCT NCT04451109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04451109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dilapan-S®: A Multicenter US E-registry
Lead sponsor
Medicem Technology s.r.o.
Phase
Observational
Overall status
Active, not recruiting
Start date
December 1, 2020
Completion date
June 30, 2025
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fetal growth retardation, gestational diabetes, high blood pressure in pregnancy, oligohydramnios, post term pregnancy, premature rupture of membrane